There is increasing interest in so-called alternative medicine. Both patients and practitioners are clearly interested in this domain and this is in striking contrast to the bright, shining edifice of evidence-based medicine.
The Food and Drug Administration has approved Onexton Gel (clindamycin phosphate and benzoyl peroxide 1.2 percent/3.75 percent, Valeant Pharmaceuticals) for the once-daily treatment of comedonal and inflammatory acne in patients 12 and older.
Treatments for acne scars are improving rapidly, although complete fixes remain impossible and repairs require long-term treatment planning and management, according to a speaker Friday at the 2014 Annual Meeting of the American Society for Dermatologic Surgery. Greg Goodman, M.D., of The Dermatology Institute of Victoria in Australia, offered attendees tips and takeaways for treating scars.
Guidelines for the diagnosis and treatment of pediatric acne developed by the American Acne Rosacea Society (AARS) and endorsed by the American Academy of Pediatrics (AAP) provide the AAP with its first-ever evidence-based guidelines for the management of this very common pediatric condition.
Biofilms are increasingly implicated as the reason why currently available acne treatments sometimes prove ineffective in acne vulgaris patients, begging the need for more effective targeted therapies directed against biofilm formation.
Active chemicals found in the neem tree (Azadirachta indica) have important benefits for a variety of skin disorders, according to one expert who spoke at the 72nd Annual Meeting of the American Academy of Dermatology.
Gluten and gluten-sensitive enteropathy have become hot topics among the lay public and in medical practices. John Zone, M.D., from the University of Utah, Salt Lake City, discusses how gluten sensitive enteropathy may impact many areas of dermatology.
I thoroughly enjoyed the lead article about “antimicrobial stewardship” in the October edition of Dermatology Times (“Antimicrobial stewardship: How dermatologists can be part of the solution, Vol. 34, No. 10). It succinctly and effectively detailed that for healthcare providers in general and dermatologists in specific, it is our duty to utilize antimicrobials appropriately.